Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.

Birthweight Genetic risk score Height Osteosarcoma Puberty timing

Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
16 Aug 2023
Historique:
received: 04 05 2023
accepted: 14 07 2023
medline: 19 8 2023
pubmed: 19 8 2023
entrez: 18 8 2023
Statut: aheadofprint

Résumé

Several studies have linked increased risk of osteosarcoma with tall stature, high birthweight, and early puberty, although evidence is inconsistent. We used genetic risk scores (GRS) based on established genetic loci for these traits and evaluated associations between genetically inferred birthweight, height, and puberty timing with osteosarcoma. Using genotype data from two genome-wide association studies, totaling 1039 cases and 2923 controls of European ancestry, association analyses were conducted using logistic regression for each study and meta-analyzed to estimate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses were conducted by case diagnosis age, metastasis status, tumor location, tumor histology, and presence of a known pathogenic variant in a cancer susceptibility gene. Genetically inferred higher birthweight was associated with an increased risk of osteosarcoma (OR =1.59, 95% CI 1.07-2.38, P = 0.02). This association was strongest in cases without metastatic disease (OR =2.46, 95% CI 1.44-4.19, P = 9.5 ×10 A genetic propensity to higher birthweight was associated with increased osteosarcoma risk, suggesting that shared genetic factors or biological pathways that affect birthweight may contribute to osteosarcoma pathogenesis.

Identifiants

pubmed: 37596165
pii: S1877-7821(23)00112-1
doi: 10.1016/j.canep.2023.102432
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102432

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

D Matthew Gianferante (DM)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Amy Moore (A)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Logan G Spector (LG)

Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.

William Wheeler (W)

Information Management Services, Rockville, MD, USA.

Tianzhong Yang (T)

Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.

Aubrey Hubbard (A)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Richard Gorlick (R)

University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ana Patiño-Garcia (A)

Department of Pediatrics and Solid Tumor Division CIMA, IdiSNA, Clínica Universidad de Navarra, Pamplona, Spain.

Fernando Lecanda (F)

Center for Applied Medical Research (CIMA)-University of Navarra, IdiSNA, and CIBERONC, Pamplona, Spain.

Adrienne M Flanagan (AM)

UCL Cancer Institute, Huntley Street, London WC1E 6BT, UK; Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.

Fernanda Amary (F)

Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.

Irene L Andrulis (IL)

Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Jay S Wunder (JS)

Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

David M Thomas (DM)

Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Mandy L Ballinger (ML)

Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Massimo Serra (M)

Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy; IRCCS Istituto Ortopedico Rizzoli, Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, Pharmacogenomics and Pharmacogenetics Research Unit, Bologna, Italy.

Claudia Hattinger (C)

Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy; IRCCS Istituto Ortopedico Rizzoli, Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, Pharmacogenomics and Pharmacogenetics Research Unit, Bologna, Italy.

Ellen Demerath (E)

Division of Epidemiology and Clinical Research, School of Public Health, UMN, USA.

Will Johnson (W)

School of Sport, Exercise, and Health Sciences, University of Loughborough, UK.

Brenda M Birmann (BM)

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Immaculata De Vivo (I)

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Graham Giles (G)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.

Lauren R Teras (LR)

Department of Population Science, American Cancer Society, Atlanta, GA, USA.

Alan Arslan (A)

Department of Obstetrics and Gynecology, New York School of Medicine, New York, NY, USA; Department of Population Health, New York University School of Medicine, New York, NY, USA.

Roel Vermeulen (R)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Jeannette Sample (J)

Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.

Neal D Freedman (ND)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Wen-Yi Huang (WY)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Stephen J Chanock (SJ)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Sharon A Savage (SA)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Sonja I Berndt (SI)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA.

Lisa Mirabello (L)

Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD, USA. Electronic address: mirabellol@nih.gov.

Classifications MeSH